Publication | Open Access

An Asian Regional Analysis of Cost-Effectiveness of Early Irbesartan Treatment versus Conventional Antihypertensive, Late Amlodipine, and Late Irbesartan Treatments in Patients with Type 2 Diabetes, Hypertension, and Nephropathy

Non-pharmacological InterventionHypertensionAsian Regional AnalysisCardiovascular DiseaseHealth PolicyAntihypertensive TherapyChronic Kidney DiseaseDiabetesCardiovascular PharmacologyType 2PharmacoeconomicsPharmacotherapyPublic HealthLate AmlodipineMedicineNephrologyAnesthesiology